Bristol-Myers Squibb Co. logo

BMY

Bristol-Myers Squibb Co.

$74.08

Earnings Summary

Revenue
$11887Mn
Net Profits
$1421Mn
Net Profit Margins
11.95%
PE Ratio
24.76

Highlights

Revenue:

Bristol-Myers Squibb Co.’s revenue jumped 1.57% since last year same period to $11887Mn in the Q2 2022. On a quarterly growth basis, Bristol-Myers Squibb Co. has generated 2.05% jump in its revenue since last 3-months.

Net Profits:

Bristol-Myers Squibb Co.’s net profit jumped 34.69% since last year same period to $1421Mn in the Q2 2022. On a quarterly growth basis, Bristol-Myers Squibb Co. has generated 11.19% jump in its net profits since last 3-months.

Net Profit Margins:

Bristol-Myers Squibb Co.’s net profit margin jumped 32.61% since last year same period to 11.95% in the Q2 2022. On a quarterly growth basis, Bristol-Myers Squibb Co. has generated 8.95% jump in its net profit margins since last 3-months.

PE Ratio:

Bristol-Myers Squibb Co.’s price-to-earnings ratio after this Q2 2022 earnings stands at 24.76.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Bristol-Myers Squibb Co. post its latest quarter earnings

EPS Estimate Current Quarter
1.84
EPS Estimate Current Year
1.84

Highlights

EPS Estimate Current Quarter:

Bristol-Myers Squibb Co.’s earning per share (EPS) estimates for the current quarter stand at 1.84 - a 2.79% jump from last quarter’s estimates.

EPS Estimate Current Year:

Bristol-Myers Squibb Co.’s earning per share (EPS) estimates for the current year stand at 1.84.

Key Ratios

Key ratios of the Bristol-Myers Squibb Co. post its Q2 2022 earnings

Earning Per Share (EPS)
1.93
Return on Assets (ROA)
0.06
Return on Equity (ROE)
0.19
Dividend Per Share (DPS)
2.11

Highlights

Earning Per Share (EPS):

Bristol-Myers Squibb Co.’s earning per share (EPS) jumped 0% since last year same period to 1.93 in the Q2 2022. This indicates that the Bristol-Myers Squibb Co. has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bristol-Myers Squibb Co.’s return on assets (ROA) stands at 0.06.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bristol-Myers Squibb Co.’s return on equity (ROE) stands at 0.19.

Dividend Per Share (DPS):

Bristol-Myers Squibb Co. declared 2.11 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-27
1.79
1.93
7.82%
2022-04-29
1.91
1.96
2.62%

Company Information

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Organisation
Bristol-Myers Squibb Co.
Headquarters
New York, New York, US
Employees
30.25K
Industry
Health Technology
CEO
Giovanni Caforio